Table 3.
Biomarker | Model | Mean PDI 1 | N (%) 2 | Median | P95 | Max | |
---|---|---|---|---|---|---|---|
AFB1 | AFM1 | MOE | 0.62 | 2.20 | 0.67 | 2.14 | 2.50 |
OTA | OTA | MOE | 0.14 | 3.52 | 110.31 | 217.05 | 270.67 |
FB1 | FB1 | HQ | 5.51 | 12.33 | 5.24 | 8.58 | 10.5 |
DON | DON+DON-3-GlcA+DON-15-GlcA | HQ | 0.08 | 0 | 0.03 | 0.28 | 0.85 |
ZEN | ZEN | HQ | 0.20 | 0.88 | 0.13 | 1.18 | 13.78 |
1 Only positive samples (≥ LOD) were considered for the calculation of dietary intake. 2 N (%), percentage of samples posing health risks (percent in all, %).